These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 33910457)
1. Prenatal screening for Down syndrome: popularity, perceptions and factors associated with acceptance or refusal of testing. Pop-Tudose ME; Armean P; Pop IV J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6505-6509. PubMed ID: 33910457 [TBL] [Abstract][Full Text] [Related]
2. Attitude, knowledge and informed choice towards prenatal screening for Down Syndrome: a cross-sectional study. Pop-Tudose ME; Popescu-Spineni D; Armean P; Pop IV BMC Pregnancy Childbirth; 2018 Nov; 18(1):439. PubMed ID: 30419853 [TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies. Audibert F; Gagnon A; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753 [TBL] [Abstract][Full Text] [Related]
5. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study. Crombag NM; Boeije H; Iedema-Kuiper R; Schielen PC; Visser GH; Bensing JM BMC Pregnancy Childbirth; 2016 May; 16(1):121. PubMed ID: 27229318 [TBL] [Abstract][Full Text] [Related]
6. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. Dick PT CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836 [TBL] [Abstract][Full Text] [Related]
7. Facilitating autonomous, confident and satisfying choices: a mixed-method study of women's choice-making in prenatal screening for common aneuploidies. Chen A; Tenhunen H; Torkki P; Peltokorpi A; Heinonen S; Lillrank P; Stefanovic V BMC Pregnancy Childbirth; 2018 May; 18(1):119. PubMed ID: 29720125 [TBL] [Abstract][Full Text] [Related]
8. Role of Psychosocial Factors and Health Literacy in Pregnant Women's Intention to Use a Decision Aid for Down Syndrome Screening: A Theory-Based Web Survey. Delanoë A; Lépine J; Turcotte S; Leiva Portocarrero ME; Robitaille H; Giguère AM; Wilson BJ; Witteman HO; Lévesque I; Guillaumie L; Légaré F J Med Internet Res; 2016 Oct; 18(10):e283. PubMed ID: 27793792 [TBL] [Abstract][Full Text] [Related]
9. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications. Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159 [TBL] [Abstract][Full Text] [Related]
12. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening. Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086 [TBL] [Abstract][Full Text] [Related]
13. Are pregnant women adequately equipped for autonomy in pregnancy screening? Thain SP; Choi CT; Yeo GS Ann Acad Med Singap; 2015 Feb; 44(2):43-9. PubMed ID: 25797816 [TBL] [Abstract][Full Text] [Related]
14. What about informed consent in first-trimester ultrasound screening for Down syndrome? Favre R; Moutel G; Duchange N; Vayssière C; Kohler M; Bouffet N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Nisand I Fetal Diagn Ther; 2008; 23(3):173-84. PubMed ID: 18417975 [TBL] [Abstract][Full Text] [Related]
15. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies. Langlois S; Duncan A; ; J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994 [TBL] [Abstract][Full Text] [Related]
17. Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy. Spencer K Prenat Diagn; 2002 Dec; 22(13):1229-32. PubMed ID: 12478639 [TBL] [Abstract][Full Text] [Related]
18. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study. Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219 [TBL] [Abstract][Full Text] [Related]
19. Women's Attitudes Toward Invasive and Noninvasive Testing When Facing a High Risk of Fetal Down Syndrome. Seror V; L'Haridon O; Bussières L; Malan V; Fries N; Vekemans M; Salomon LJ; Ville Y; JAMA Netw Open; 2019 Mar; 2(3):e191062. PubMed ID: 30924894 [TBL] [Abstract][Full Text] [Related]
20. [Refusal of prenatal HIV-testing: a case study in Abidjan (Côte d'Ivoire)]. Desgrées du Loû A; Brou H; Djohan G; Tijou-Traoré A; Sante; 2007; 17(3):133-41. PubMed ID: 18180214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]